Dawes Fretzin Clinical Res LLC

Indianapolis, Indiana 46256

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Urticaria

Studies at this site

• A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling
• A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria — Completed